PEGylation of microspheres for therapeutic embolization: Preparation, characterization and biological performance evaluation

Biomaterials

Volumn 28, Issue 6, 2007, Pages 1198-1208

  Madani, Faten ^a   Bessodes, Michel ^b   Lakrouf, Amina ^a   Vauthier, Christine ^a   Scherman, Daniel ^b   Chaumeil, Jean Claude ^a,c  

^a UNIV PARIS SUD   (France)

^b INSERM   (France)

^c Pharmacie Centrale des Hopitaux   (France)

Author keywords

Complement activation; Embolization; Grafting; Microspheres (MS); PEGylation

Indexed keywords

BIOLOGICAL MEMBRANES; BLOOD; FOURIER TRANSFORM INFRARED SPECTROSCOPY; GRAFTS; HYDROPHILICITY; ION EXCHANGE; SCANNING ELECTRON MICROSCOPY;

COMPLEMENT ACTIVATION; EMBOLIZATION; MICROSPHERES (MS); PEGYLATION;

POLYETHYLENE GLYCOLS;

(3 AMINOPROPYL)TRIETHOXYSILANE; ANTIINFLAMMATORY AGENT; INDOMETACIN; MACROGOL; MICROSPHERE; SILANE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; ARTIFICIAL EMBOLISM; COMPLEMENT ACTIVATION; HYDROPHILICITY; INFRARED SPECTROSCOPY; ION EXCHANGE; MASS SPECTROMETRY; MORPHOLOGY; POLYMERIZATION; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY;

BIOCOMPATIBLE MATERIALS; COMPLEMENT ACTIVATION; EMBOLIZATION, THERAPEUTIC; HUMANS; MATERIALS TESTING; PARTICLE SIZE; POLYETHYLENE GLYCOLS; SURFACE PROPERTIES;

EID: 33751350040     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2006.10.017     Document Type: Article

References (46)

1. Beaujeux R., Laurent A., Wassef M., Casasco A., Gobin Y.P., Aymard A., et al. Trisacryl gelatin microspheres for therapeutic embolization, II: preliminary clinical evaluation in tumors and arteriovenous malformations. Am J Neuroradiol 17 (1996) 541-548
2. Germano I.M., Davis R.L., Wilson C.B., and Hieshima G.B. Histopathological follow-up study of 66 cerebral arteriovenous malformations after therapeutic embolization with polyvinyl alcohol. J Neurosurg 76 (1992) 607-614
3. Gobin Y.P., Vinuela F., Vinters H.V., Ji C., and Chow K. Embolization with radiopaque microbeads of polyacrylonitrile hydrogel: evaluation in swine. Radiology 214 (2000) 113-119
4. Laurent A., Wassef M., Drouet L., Pignaud G., and Merland J.J. Etude histologique de plusieurs matériaux d'embolisation et d'un nouveau type de matériel sphérique et adhésif. Innov Tech Biol Med 10 (1989) 358-366
5. Laurent A., Beaujeux R., Wassef M., Rufenacht D., Boschetti E., and Merland J.J. Trisacryl gelatin microspheres for therapeutic embolization, I: development and in vitro evaluation. Am J Neuroradiol 17 (1996) 533-540
6. Domas L., Beaujeux R., Wassef M., Rufenacht D., Boschetti E., and Merland J.J. Analyse morphologique et indice de forme des particules d'embolisation. Innov Tech Biol Med 14 (1993) 437-448
7. Boudy V., Lewest J.M., Laurent A., Labarre D., Le Pallec G., Gard C., et al. Mise au point de microsphères pour embolisation thérapeutic définitive contenant de l'indométacine. Act Pharm Biol Clin (1997) 398-402
8. Pelage J.P., Le Dref O., Beregi J.P., Nonent M., Robert Y., Cosson M., et al. Limited uterine artery embolization with tris-acryl gelatin microspheres for uterine fibroids. J Vasc Interv Radiol 14 (2003) 15-20
9. Altman J., Dulas D., and Bache R.J. Effect of cyclooxygenase blockade on blood flow through well-developed coronary collateral vessels. Circ Res 70 (1992) 1091-1098
10. Gbadamosi J.K., Hunter A.C., and Moghimi S.M. PEGylation of microspheres generates a heterogeneous population of particles with differential surface characteristics and biological performance. FEBS Lett 532 (2002) 338-344
11. Owens D.E., and Peppas N.A. Opsonization, biodistribution and pharmacokinetics of polymeric nanoparticles. Int J Pharm 307 (2006) 93-102
12. Chretien C., Boudy V., Allain P., and Chaumeil J.C. Indomethacin release from ion-exchange microspheres: impregnation with alginate reduces release rate. J Control Release 96 (2004) 369-378
13. Fields R. Estimation of amino groups using TNBS. Methods in enzymology 25 (1972) 464-469
14. Salmaso S., Semenzato A., Bersania S., Chinol M., Paganelli G., and Caliceti P. Preparation and characterization of active site protected poly(ethylene glycol)-avidin bioconjugates. Biochim Biophys Acta 1726 (2005) 57-66
15. Giangthy N.T., Jason P.F., and Glen S.K. Methoxypoly(ethylene glycol)-conjugated carboxypeptidase A for solid tumor targeting. Part 1: synthesis and characterization. J Control Release 104 (2005) 129-139
16. Tattini V., Parra D.F., Polakiewicz B., and Pitombo R.N.M. Effect of lyophilization on the structure and phase changes of PEGylated-bovine serum albumin. Int J Pharm 304 (2005) 124-134
17. Jo S., Engel P.S., and Mikos A.G. Synthesis of poly(ethylene glycol)-tethered poly(propylene fumarate) and its modification with GRGD peptide. Polymer 41 (2000) 7594-7605
18. Mao S., Shuai X., Unger F., Wittmar M., Xie X., and Kissel T. Synthesis, characterization and cytotoxicity of poly(ethylene glycol)-graft-trimethyl chitosan block copolymers. Biomaterials 26 (2005) 6343-6356
19. Baleux B., and Champetier G. Dosage colorimétrique d'agents de surface non ioniques poly oxyéthylènes à l'aide d'une solution iodo-iodurée. Paris: CR Acad Sci 274 (1972) 1617-1620
20. Boudy V., Voute N., Pradeau D., and Chaumeil J.C. Adsorption of an ionizable drug onto microspheres: experimental and modeling studies. Int J Pharm 239 (2002) 13-22
21. Vittaz M., Bazile D., Spenlehauer G., Verrecchia T., Veillard M., Puisienx F., et al. Effect of PEO surface density on long-circulating PLA-PEO nanoparticles which are very low complement activators. Biomaterials 17 (1996) 1575-1581
22. Kazatchkine M.D., Hauptmann G., and Nydegger U.E. Techniques du Complement (1986), INSERM, Paris p. 22-33
23. Laurell C.B. Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies. Anal Biochem 15 (1966) 45-52
24. Roberts M.J., Bentley M.D., and Harris J.M. Chemistry for peptide and protein PEGylation. Adv Drug Deliv Rev 54 (2002) 459-476
25. Francesco V.M. Peptide and protein PEGylation: a review of problems and solutions. Biomaterials 22 (2001) 405-417
26. Roberts M.J., Bentley M.D., and Harris J.M. Chemistry for peptide and protein PEGylation. Adv Drug Deliv 54 (2002) 459-476
27. Girot P., and Boschetti E. Physicochemical and chromatographic properties of new ion exchangers: I. CM Trisacryl. J Chromatogr 213 (1981) 389-395
28. Park S.J., and Kim S.H. Preparation and characterization of biodegradable poly(l-lactide)/poly(ethylene glycol) microcapsules containing erythromycin by emulsion solvent evaporation technique. J Colloid Interface Sci 271 (2004) 336-341
29. Craig D.Q.M., and Newton J.M. Chains characterization of poly ethylene glycol using differential scanning calorimetry. Int J Pharm 74 (1991) 33-41
30. Chatham S.M. The use of bases in SSM formulations. STP Pharm 3 (1987) 575-582
31. Buckley C.P., and Kovacs A.J. Melting behaviour of low molecular weight poly(ethylene oxid) fractions. 2. Folded chain crystals. Coll Polym Sci 254 (1976) 695-715
32. Wang J., Pan C.J., Huang N., Sun H., Yang P., Leng Y.X., et al. Surface characterization and blood compatibility of poly(ethylene terephthalate) modified by plasma surface grafting. Surf Coat Tech 196 (2005) 307-311
33. Bhadra D., Bhadra S., Jain S., and Jain N.K. A PEGylated dendritic nanoparticulate carrier of fluorouracil. Int J Pharm 257 (2003) 111-124
34. Labarre D., Laurent A., Lautier A., Bouhni S., Kerbellec L., Lewest J.M., et al. Complement activation by substituted polyacrylamide hydrogels for embolisation and implantation. Biomaterials 23 (2002) 2319-2327
35. Thomas JD. Novel associated PVA/PVP hydrogels for nucleus pulposus replacement. MSc. thesis, Drexel Univ, Philadelphia, PA, 2001.
36. In: Charles, JP, editor. The Aldrich library of infrared spectra: Edit, vol. 3, Milwaukee, WI, 1981.
37. Coates J. In: Meyers R.A. (Ed). Encyclopedia of Analytical Chemistry (2000), Wiley, Chichester 10815-10837
38. Peppas N.A., and Wright S.L. Drug diffusion and binding in ionizable interpenetrating networks from poly(vinyl alcohol) and poly(acrylic acid). Eur J Pharm Biopharm 46 (1998) 15-29
39. Sahlin J.J., and Peppas N.A. Enhanced hydrogel adhesion by polymer interdiffusion: use of linear poly(ethylene glycol) as an adhesion promoter. J Biomater Sci Polym Ed 8 (1997) 421-436
40. Herman S.M., Rodrigo L.O., and Alexandra A.P. Characterization of poly(vinyl alcohol)/poly(ethylene glycol) hydrogels and PVA-derived hybrids by small-angle X-ray scattering and FTIR Spectroscopy. Polymers 45 (2004) 7192-7203
41. Law S.K.A., and Dodds A.W. The internal thioester and the covalent binding properties of the complement proteins C3 and C4. Protein Sci 6 (1997) 263-274
42. Fontaine M., Aubert J.P., Joisel F., and Lebreton J.P. Structure-function relations in the third component of human complement (C3): I. Hydrophobic sites. Mol Immunol 19 (1982) 27-37
43. Moghimi S.M. Chemical camouflage of nanospheres with a poorly reactive surface: towards development of stealth and target-specific nanocarriers. Biochim Biophys Acta 1590 (2002) 131-139
44. Labarre D., Vauthier C., Chauvierre C., Petri B., Muller R., and Chehimi M.M. Interactions of blood proteins with poly(isobutylcyanoacrylate) nanoparticles decorated with a polysaccharidic brush. Biomaterials 26 (2005) 5075-5084
45. Murakami Y., Iwata H., Kitano E., Kitamura H., and Ikada Y. Interaction of poly(2-acrylamido 2-methylpropane sulfonate)-grafted polystyrene beads with cationic complement proteins. J Biomater Sci Polym Ed 12 (2001) 451-465
46. Janatova J., Cheung A.K., and Parker C.J. Biomedical polymers differ in their capacity to activate complement. Complement Inflamm 8 (1991) 61-69